Anika To Participate in December 2024 Investor Conferences
Anika To Participate in December 2024 Investor Conferences
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
马萨诸塞州贝德福德，2024年11月22日（环球新闻社） - 阿尼卡疗法公司（纳斯达克：ANIK），一家全球关节保护公司在早期干预骨科领域，今天宣布高级管理层将参加以下即将举行的会议。
36th Annual Piper Sandler Healthcare Conference in New York, NY on December 3rd. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer, are scheduled to present at 10:30am ET. Management will also participate in one-on-one investor meetings throughout the event.
第36届派杰投资医疗保健大会将于12月3日在纽约举行。阿尼卡总裁兼首席执行官谢丽尔·布兰查德博士和首席财务官史蒂夫·格里芬执行副总裁将于上午10:30分进行演讲。管理团队还将在活动期间参加一对一投资者会议。
Sidoti Small-Cap Virtual Conference on December 5th. Steve Griffin, Executive Vice President and Chief Financial Officer, is scheduled to present at 10:45am ET. Mr. Griffin will also participate in one-on-one investor meetings throughout the event.
Sidoti小市值虚拟会议将于12月5日举行。首席财务官史蒂夫·格里芬执行副总裁将于上午10:45分进行演讲。格里芬先生还将参加一对一投资者会议。
The Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York, NY on December 11th. Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer will participate in one-on-one investor meetings throughout the event.
Benchmark公司第13届年度一对一投资者会议将于12月11日在纽约举行。阿尼卡总裁兼首席执行官谢丽尔·布兰查德博士和首席财务官史蒂夫·格里芬执行副总裁将参加一对一投资者会议。
For more information about these events or to schedule a one-on-one meeting with Anika's senior management, please contact Anika's Investor Relations at investorrelations@anika.com.
如需了解更多有关这些活动或安排与阿尼卡高级管理团队的一对一会议，请联系阿尼卡的投资者关系部 investorrelations@anika.com。
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit .
Anika Therapeutics，Inc. (NASDAQ：ANIK)是一家全球联合保护公司，为早期干预矫形护理创造和交付有意义的进步。利用我们在透明质酸和植入物解决方案方面的核心专业知识，我们与临床医生合作，提供最小侵入式的产品，为世界各地的人们恢复积极生活。我们的重点是矫形学中的高机会空间，包括骨关节炎疼痛管理、再生解决方案、运动医学和关节表面解决方案，我们的产品在关键的护理场所，包括日间手术中心中进行高效输送。Anika的全球运营总部位于马萨诸塞州波士顿外部。有关Anika的更多信息，请访问。
阿尼卡疗法股份有限公司（纳斯达克：ANIK）是一家全球关节保护公司，致力于为早期干预骨科护理领域带来有意义的创新。利用我们在透明质酸和植入物解决方案方面的核心专长，我们与临床医生合作，提供能够恢复全球人民积极生活的微创产品。我们的重点是骨科学中的高机遇领域，包括骨关节炎疼痛管理和再生解决方案，并在包括门诊手术中心在内的关键护理场所高效提供我们的产品。阿尼卡的全球业务总部位于马萨诸塞州波士顿外。有关阿尼卡的更多信息，请访问。
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
阿尼卡, 阿尼卡疗法, CINGAL, HYALOFASt, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSEt, 和 Anika 商标是 Anika Therapeutics, Inc. 或其子公司的商标，或已许可给 Anika Therapeutics, Inc. 供其使用。
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
投资者查询：
阿尼卡疗法公司
马特·霍尔，781-457-9554
董事，企业发展和投资者关系
investorrelations@anika.com